← back to search

Peter Pickkers

Nordic Bioscience (Denmark) · NL
Area of research
Epidemiology · Immunology
Research interest
Research interests include Sepsis Diagnosis and Treatment, Immune Response and Inflammation, Acute Kidney Injury Research, and Intensive Care Unit Cognitive Disorders.
h-index
100
citations
38,017
works
731
NIH funding
primary concept
email

Recent publications

State of the art: Renal recovery after AKI - from basic science to clinical practice
Intensive Care Medicine 2025cited by 7position: middledoi
The pathophysiology of sepsis and precision-medicine-based immunotherapy
Nature Immunology 2024cited by 300position: middledoi
Sepsis-associated acute kidney injury: recent advances in enrichment strategies, sub-phenotyping and clinical trials
Critical Care 2024cited by 72position: middledoi
Phase-3 trial of recombinant human alkaline phosphatase for patients with sepsis-associated acute kidney injury (REVIVAL)
Intensive Care Medicine 2024cited by 66position: firstdoi
Sepsis-associated acute kidney injury: consensus report of the 28th Acute Disease Quality Initiative workgroup
Nature Reviews Nephrology 2023cited by 641position: middledoi
Sepsis-associated acute kidney injury—treatment standard
Nephrology Dialysis Transplantation 2023cited by 96position: middledoi
Resolving sepsis-induced immunoparalysis via trained immunity by targeting interleukin-4 to myeloid cells
Nature Biomedical Engineering 2023cited by 81position: middledoi
Immunosuppressive effects of circulating bile acids in human endotoxemia and septic shock: patients with liver failure are at risk
Critical Care 2023cited by 22position: middledoi
Age Moderates the Effect of Obesity on Mortality Risk in Critically Ill Patients With COVID-19: A Nationwide Observational Cohort Study*
Critical Care Medicine 2023cited by 17position: middledoi
A guide to immunotherapy for COVID-19
Nature Medicine 2022cited by 334position: middledoi
Impaired ketogenesis ties metabolism to T cell dysfunction in COVID-19
Nature 2022cited by 154position: middledoi
Plasma exchange in the intensive care unit: a narrative review
Intensive Care Medicine 2022cited by 132position: middledoi
New drugs for acute kidney injury
Intensive Care Medicine 2022cited by 39position: firstdoi
The 2021 Dutch Working Party on Antibiotic Policy (SWAB) guidelines for empirical antibacterial therapy of sepsis in adults
BMC Infectious Diseases 2022cited by 28position: middledoi
Swarm Learning for decentralized and confidential clinical machine learning
Nature 2021cited by 822position: middledoi
Acute kidney injury in the critically ill: an updated review on pathophysiology and management
Intensive Care Medicine 2021cited by 503position: firstdoi
Sepsis-Induced Immunosuppression
Annual Review of Physiology 2021cited by 335position: middledoi
Monitoring circulating dipeptidyl peptidase 3 (DPP3) predicts improvement of organ failure and survival in sepsis: a prospective observational multinational study
Critical Care 2021cited by 74position: middledoi
COVID-19-associated acute kidney injury: consensus report of the 25th Acute Disease Quality Initiative (ADQI) Workgroup
Nature Reviews Nephrology 2020cited by 701position: middledoi
Recommendations on Acute Kidney Injury Biomarkers From the Acute Disease Quality Initiative Consensus Conference
JAMA Network Open 2020cited by 638position: middledoi
Monocytic HLA-DR expression kinetics in septic shock patients with different pathogens, sites of infection and adverse outcomes
Critical Care 2020cited by 154position: middledoi
How to ventilate obese patients in the ICU
Intensive Care Medicine 2020cited by 151position: middledoi
Proenkephalin: A New Biomarker for Glomerular Filtration Rate and Acute Kidney Injury
˜The œNephron journals/Nephron journals 2020cited by 84position: middledoi
Targeting the Heme-Heme Oxygenase System to Prevent Severe Complications Following COVID-19 Infections
Antioxidants 2020cited by 84position: middledoi
Suboptimal Dosing of Fluconazole in Critically Ill Patients: Time To Rethink Dosing
Antimicrobial Agents and Chemotherapy 2020cited by 39position: middledoi
Publisher Correction: COVID-19-associated acute kidney injury: consensus report of the 25th Acute Disease Quality Initiative (ADQI) Workgroup
Nature Reviews Nephrology 2020cited by 25position: middledoi
Obesity in the critically ill: a narrative review
Intensive Care Medicine 2019cited by 545position: middledoi
Quality Improvement Goals for Acute Kidney Injury
Clinical Journal of the American Society of Nephrology 2019cited by 240position: middledoi
Effect of Selepressin vs Placebo on Ventilator- and Vasopressor-Free Days in Patients With Septic Shock
JAMA 2019cited by 139position: middledoi
Cardiac and Vascular Surgery–Associated Acute Kidney Injury: The 20th International Consensus Conference of the ADQI (Acute Disease Quality Initiative) Group
Journal of the American Heart Association 2018cited by 349position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Marlies Ostermann · Guy's and St Thomas' NHS Foundation Trust7 papers (2017–2025)John A. Kellum · University of Pittsburgh6 papers (2013–2025)Michael Joannidis · Bicêtre Hospital5 papers (2017–2025)Matthieu Legrand · University of California, San Francisco5 papers (2020–2025)Alexander Zarbock · University of California, San Francisco5 papers (2017–2025)John R. Prowle · Queen Mary University of London4 papers (2017–2025)Ravindra L. Mehta · University of California San Diego4 papers (2017–2024) · 4 papers (2017–2022)Miet Schetz · KU Leuven4 papers (2017–2021)W. Joost Wiersinga · Centrum Wiskunde & Informatica3 papers (2022–2024)Lui G. Forni · Royal Surrey NHS Foundation Trust3 papers (2017–2025)Tom van der Poll · Biology of Infection3 papers (2021–2024)Eric A. J. Hoste · Ghent University Hospital3 papers (2017–2021)Evangelos J. Giamarellos‐Bourboulis · Ingham Institute3 papers (2013–2024) · 3 papers (2015–2022)Dylan W. de Lange · University of Applied Sciences Utrecht3 papers (2015–2023)Mihai G. Netea · Eindhoven University of Technology2 papers (2022–2024)Raghavan Murugan · University of Pittsburgh2 papers (2018–2020)Leo Koenderman · Utrecht University2 papers (2017–2017) · 2 papers (2019–2020)